132 related articles for article (PubMed ID: 35285672)
1. Inhaled Dry Powder Mannitol Treatment in Pediatric Patients with Cystic Fibrosis: Evaluation of Clinical Data in a Real-World Setting.
Duman I; Ünal G; Yilmaz AI; Güney AY; Durduran Y; Pekcan S
Pediatr Allergy Immunol Pulmonol; 2022 Mar; 35(1):19-26. PubMed ID: 35285672
[No Abstract] [Full Text] [Related]
2. Inhaled mannitol for cystic fibrosis.
Nevitt SJ; Thornton J; Murray CS; Dwyer T
Cochrane Database Syst Rev; 2020 May; 5(5):CD008649. PubMed ID: 32358807
[TBL] [Abstract][Full Text] [Related]
3. Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial.
De Boeck K; Haarman E; Hull J; Lands LC; Moeller A; Munck A; Riethmüller J; Tiddens H; Volpi S; Leadbetter J; Charlton B; Malfroot A;
J Cyst Fibros; 2017 May; 16(3):380-387. PubMed ID: 28258928
[TBL] [Abstract][Full Text] [Related]
4. Comparison of inhaled mannitol/dornase alfa combination and daily dornase alfa alone in children with cystic fibrosis.
Ademhan Tural D; Yalçın E; Emiralioglu N; Ozsezen B; Sunman B; Nayir Buyuksahin H; Guzelkas I; Dogru D; Ozcelik U; Kiper N
Pediatr Pulmonol; 2022 Jan; 57(1):142-151. PubMed ID: 34687284
[TBL] [Abstract][Full Text] [Related]
5. Inhaled mannitol for cystic fibrosis.
Nolan SJ; Thornton J; Murray CS; Dwyer T
Cochrane Database Syst Rev; 2015 Oct; (10):CD008649. PubMed ID: 26451533
[TBL] [Abstract][Full Text] [Related]
6. Comparison of inhaled mannitol, daily rhDNase and a combination of both in children with cystic fibrosis: a randomised trial.
Minasian C; Wallis C; Metcalfe C; Bush A
Thorax; 2010 Jan; 65(1):51-6. PubMed ID: 19996349
[TBL] [Abstract][Full Text] [Related]
7. Mannitol dry powder for inhalation: in patients with cystic fibrosis.
Burness CB; Keating GM
Drugs; 2012 Jul; 72(10):1411-21. PubMed ID: 22755516
[TBL] [Abstract][Full Text] [Related]
8. Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study.
Bilton D; Robinson P; Cooper P; Gallagher CG; Kolbe J; Fox H; Jaques A; Charlton B;
Eur Respir J; 2011 Nov; 38(5):1071-80. PubMed ID: 21478216
[TBL] [Abstract][Full Text] [Related]
9. Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study.
Aitken ML; Bellon G; De Boeck K; Flume PA; Fox HG; Geller DE; Haarman EG; Hebestreit HU; Lapey A; Schou IM; Zuckerman JB; Charlton B;
Am J Respir Crit Care Med; 2012 Mar; 185(6):645-52. PubMed ID: 22198974
[TBL] [Abstract][Full Text] [Related]
10. Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis.
Tarrant BJ; Le Maitre C; Romero L; Steward R; Button BM; Thompson BR; Holland AE
Respirology; 2017 Aug; 22(6):1084-1092. PubMed ID: 28397992
[TBL] [Abstract][Full Text] [Related]
11. Bronchial provocation testing with dry powder mannitol in children with cystic fibrosis.
Minasian C; Wallis C; Metcalfe C; Bush A
Pediatr Pulmonol; 2008 Nov; 43(11):1078-1084. PubMed ID: 18972410
[TBL] [Abstract][Full Text] [Related]
12. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study.
Robinson M; Daviskas E; Eberl S; Baker J; Chan HK; Anderson SD; Bye PT
Eur Respir J; 1999 Sep; 14(3):678-85. PubMed ID: 10543292
[TBL] [Abstract][Full Text] [Related]
13. Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis.
Daviskas E; Anderson SD; Jaques A; Charlton B
Chest; 2010 Apr; 137(4):861-8. PubMed ID: 19880909
[TBL] [Abstract][Full Text] [Related]
14. Pooled analysis of two large randomised phase III inhaled mannitol studies in cystic fibrosis.
Bilton D; Bellon G; Charlton B; Cooper P; De Boeck K; Flume PA; Fox HG; Gallagher CG; Geller DE; Haarman EG; Hebestreit HU; Kolbe J; Lapey A; Robinson P; Wu J; Zuckerman JB; Aitken ML;
J Cyst Fibros; 2013 Jul; 12(4):367-76. PubMed ID: 23234802
[TBL] [Abstract][Full Text] [Related]
15. Effect of inhaled dry powder mannitol on mucus and its clearance.
Daviskas E; Rubin BK
Expert Rev Respir Med; 2013 Feb; 7(1):65-75. PubMed ID: 23362816
[TBL] [Abstract][Full Text] [Related]
16. [Effect of rhDNase on the respiratory function and nutritional status of children and adolescents with mucoviscidosis].
Wizla-Derambure N; Michaud L; Sardet A; Deschildre A; Loeuille GA; Tassin E; Loire N; Buisine C; Boutry E; Dias J; Hecquet F; Turck D
Arch Pediatr; 1998 Apr; 5(4):378-83. PubMed ID: 9759156
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of inhaled dry-powder mannitol in adults with cystic fibrosis: An international, randomized controlled study.
Flume PA; Amelina E; Daines CL; Charlton B; Leadbetter J; Guasconi A; Aitken ML
J Cyst Fibros; 2021 Nov; 20(6):1003-1009. PubMed ID: 33715994
[TBL] [Abstract][Full Text] [Related]
18. Inhaled mannitol for the treatment of cystic fibrosis.
Hurt K; Bilton D
Expert Rev Respir Med; 2012 Feb; 6(1):19-26. PubMed ID: 22283575
[TBL] [Abstract][Full Text] [Related]
19. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.
Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B;
Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664
[TBL] [Abstract][Full Text] [Related]
20. Airway inflammation after treatment with aerosolized deoxyribonuclease in cystic fibrosis.
Henry RL; Gibson PG; Carty K; Cai Y; Francis JL
Pediatr Pulmonol; 1998 Aug; 26(2):97-100. PubMed ID: 9727759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
